Invention Grant
- Patent Title: 5-HT3 receptor antagonists
-
Application No.: US15150013Application Date: 2016-05-09
-
Publication No.: US09670229B2Publication Date: 2017-06-06
- Inventor: Stephen Hitchcock , Holger Monenschein , Holly Reichard , Huikai Sun , Shota Kikuchi , Todd Macklin , Maria Hopkins
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agent Matthew J. Russo; David M. Stemerick
- Main IPC: C07D519/00
- IPC: C07D519/00 ; C07D498/08 ; C07D471/04 ; C07D451/12 ; C07D221/22 ; A61K31/19 ; A61K31/5386 ; C07C53/40 ; C07D453/02 ; C07D471/08 ; C07C53/18
Abstract:
The present invention provides 5-HT3 receptor antagonists of Formula (I): which are useful for the treatment of diseases treatable by inhibition of 5-HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Public/Granted literature
- US20160251373A1 5-HT3 RECEPTOR ANTAGONISTS Public/Granted day:2016-09-01
Information query
